Is HbA1c a risk factor for type 2 diabetic subjects without macro and micro vascular complications?

References

• Alberti KG, Zimmet P, Shaw J. (2005). IDF Epidemiology task force consensus group. The metabolic syndrome: A new worldwide definition. Lancet 366:1059–62.
   PubMed Web of Science ®Google Scholar
• ADA (American Diabetes Association). (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62–9.
   PubMed Web of Science ®Google Scholar
• ADA (American Diabetes Association). (2011). Standards of medical care in diabetes. Diabetes Care 34 (Suppl. 1): S4–61.
   PubMedGoogle Scholar
• Andersen GE, Christiansen JS, Mortensen HB, Christiansen KM, Pedersen-Bjergaard L, Kastrup KW, Vestermark S. (1983). Plasma lipid and lipoprotein in type 1 diabetic children and adolescent in relation to metabolic regulation, obesity and genetic hyperlipoproteinemia. Actu paediator Scand 72:361–65.
   PubMedGoogle Scholar
• Aronson D, Rayfield JE. (2002). How hyperglycemia promotes atherosclerosis: Molecular mechanisms. Cardiovasc Diabetol 1:1–10.
   PubMed Web of Science ®Google Scholar
• Assmann G, Schriewer H, Schmitz G, Hägele EO. (1983) Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid/MgCl2. Clin Chem 29: 2026–30.
   PubMed Web of Science ®Google Scholar
• Berry C, Tardif JC, Bourassa MG. (2007). Coronary heart disease in patients with diabetes: part I: recent advances in prevention and non invasive management. J Am Coll Cardiol 49:631–42.
   PubMed Web of Science ®Google Scholar
• Coutinho M, Gerstein H, Wang Y, Yusuf S. (1999). The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233–40.
   PubMed Web of Science ®Google Scholar
• Diabetes Prevention Program Research Group. (2005). Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program. Diabetes Care 28:2472–9.
   PubMed Web of Science ®Google Scholar
• Erciyas F, Taneli F, Arslan B, Uslu Y. (2004). Glycemic control, oxidative stress and lipid profile in children with type 1 diabetes mellitus. Arch Med Res 35:134–40.
   PubMed Web of Science ®Google Scholar
• NCEP. (2001). Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [special communication]. JAMA 285:2486–97.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499–502.
   PubMed Web of Science ®Google Scholar
• Gerich JE. (2003). Clinical significance, pathogenesis and management of postprandial hyperglycemia. Arch Intern Med 163:1306–16.
   PubMed Web of Science ®Google Scholar
• Ito C, Maeda R, Ishida S, Sasaki H, Harada H. (2000). Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 50:225–30.
   PubMed Web of Science ®Google Scholar
• Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N. (2001). Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). Br Med J 322:15–18.
   PubMed Web of Science ®Google Scholar
• Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Li JK, So WY, Chan WB, Cockram CS. (1998). Glycated hemoglobin and cardiovascular risk fac-tors in Chinese subjects with normal glucose tolerance. Diabet Med 15: 573–8.
   PubMed Web of Science ®Google Scholar
• Morrison EY (1999). Diabetes in the Caribbean. Caribbean Health 2(2):9–10.
   Google Scholar
• Ohta T, Nishiyama S, Nakamura T, Saku K, Maung KK, Matsuda I. (1998). Predominance of large low density lipoprotein particles and lower fractional esterification rate of cholesterol in high density lipoprotein in children with insulin-dependent diabetes mellitus. Eur J Pediatr 157:276–81.
   PubMed Web of Science ®Google Scholar
• Reaven GM. (1988). Banting lecture: Role of insulin resistance in human disease. Diabetes 37:1595–1607.
   PubMed Web of Science ®Google Scholar
• Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. (2002). Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications trial. Diabetes Care 25:275–8.
   PubMed Web of Science ®Google Scholar
• Rosediani M, Azidah AK, Mafauzy M. (2006). Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine. Med J Malaysia 61:67–71.
   PubMedGoogle Scholar
• Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH. (2004). Metaanalysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med, 141:421–31.
   PubMed Web of Science ®Google Scholar
• Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. (2006). HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 29: 877–82.
   PubMed Web of Science ®Google Scholar
• Stamler J, Vaccaro O, Neaton JD, Wentworth D. (1993). Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–44.
   PubMed Web of Science ®Google Scholar
• Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, Krähenbühl S, Diem P. (2006). Glycemic control and macrovascular disease in type 1 and 2 diabetes mellitus: A meta-analysis of randomized trials. Am Heart J 152: 27–38.
   PubMed Web of Science ®Google Scholar
• Sultan A, Thuan JF, Avignon A. (2006). Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions? Diabetes Metab 32:559–67.
   PubMed Web of Science ®Google Scholar
• UKPDS (UK Prospective Diabetes Study) Group. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321:405–12.
   PubMed Web of Science ®Google Scholar
• Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. (2005). Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 28:514–20.
   PubMed Web of Science ®Google Scholar